Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.23
-0.0200-0.03%
Volume:1.94M
Turnover:140.38M
Market Cap:11.33B
PE:62.27
High:72.33
Open:72.26
Low:72.21
Close:72.25
52wk High:72.62
52wk Low:43.20
Shares:156.82M
Float Shares:155.81M
Volume Ratio:1.05
T/O Rate:1.25%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.67%
PB:5.37
PE(LYR):62.27

Loading ...

Press Release: Groupe Dynamite Appoints AI and TECH Leader, MR. Martin KON, to ITS BOARD of Directors

Dow Jones
·
Jul 23

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Press Release: YSX TECH. CO. LTD Reports Full Year 2026 Financial Results

Dow Jones
·
Jul 11

RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62

MT Newswires Live
·
Jul 09

U.S. Research Roundup-applied Materials, CME Group, NASDAQ

Reuters
·
Jul 09

Bio-techne Corp : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $73 from $62

THOMSON REUTERS
·
Jul 09

Bio-Techne Expands AI-Engineered Designer Protein Portfolio

MT Newswires Live
·
Jul 08

Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Maintains $73 Price Target

MT Newswires Live
·
Jul 06

Merck KGaA downgraded to Hold from Buy at HSBCBio-Techne

TIPRANKS
·
Jul 06

Piper Sandler Adjusts Bio-Techne Price Target to $73 From $60, Maintains Neutral Rating

MT Newswires Live
·
Jul 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Jul 01

Merck Kgaa Agrees to Buy Bio-techne for USD 73 a Share in Cash

Reuters
·
Jul 01

Bio-techne Cut to Hold from Buy by Benchmark

Dow Jones
·
Jun 30

Benchmark Downgrades Bio-Techne to Hold From Buy

MT Newswires Live
·
Jun 30

Bio-techne Corp : Benchmark Cuts to Hold from Buy

THOMSON REUTERS
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Bio-Techne downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jun 30

Bio-techne Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jun 29

Citigroup Downgrades Bio-Techne to Neutral From Buy, Adjusts PT to $73 From $70

MT Newswires Live
·
Jun 29

Buzz-us Stocks Weekly: AI Reality

Reuters
·
Jun 29